Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 10,808,747 $ 10,867,050
Accounts receivable 34,441 72,609
Prepaid expenses 860,780 784,920
Other current assets 493,351 447,566
Total Current Assets 12,197,319 12,172,145
Property and equipment, net 5,304,805 5,393,012
Operating lease right-of-use assets 490,468 619,392
Intangible assets, net 48,276 110,505
Total Assets 18,040,868 18,295,054
Current Liabilities    
Accounts payable 3,059,844 3,043,008
Accrued liabilities 2,867,610 2,872,247
Deferred revenue 10,000,000 10,000,000
Management and directors' fees payable 59,982 71,119
Current portion of long-term debt 1,258,193 1,066,700
Current portion of finance lease liabilities 46,279 46,014
Current portion of operating lease liabilities 194,772 245,163
Current portion of grant repayable 50,349 41,836
Warrant liability 117,115 0
Total Current Liabilities 17,654,144 17,386,087
Long-term debt, net of current portion 2,086,200 2,779,240
Finance lease liabilities, net of current portion 395,390 436,132
Operating lease liabilities, net of current portion 323,957 400,091
Grant repayable, net of current portion 432,486 420,466
Total Long-Term Liabilities 3,238,033 4,035,929
Total Liabilities 20,892,177 21,422,016
Stockholders' Equity (Deficit)    
Common stock issued and outstanding: 78,342,417 shares and 57,873,379 shares, respectively 78,343 57,873
Additional paid-in capital 191,517,500 164,397,468
Accumulated other comprehensive income 239,622 227,097
Accumulated deficit (193,878,257) (167,257,429)
Total VolitionRx Limited Stockholders' Equity (Deficit) (2,042,792) (2,574,991)
Non-controlling interest (808,517) (551,971)
Total Stockholders' Equity (Deficit) (2,851,309) (3,126,962)
Total Liabilities and Stockholders' Equity (Deficit) $ 18,040,868 $ 18,295,054